In vitro activity of ertapenem against bacterial isolates from cancer patients.
Rolston
Kenneth V I
KV
Section of Infectious Diseases, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, USA. krolston@mail.mdanderson.org
LeBlanc
Barbara M
BM
Streeter
Harriet
H
Ho
Dah H
DH
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001424:Bacterial Infections / Q000382:microbiology*; D000077727:Ertapenem; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D007769:Lactams; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D007769:Lactams; D047090:beta-Lactams; D000077727:Ertapenem